Replies to post #15612 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Because of the way the trial is set-up the only positive I can take from their data is the CA19.9 marker info.

While the marker info looks positive it doesn't seem like many onc's are encouraging their patients into the phII portion of the trial.